Global Celiac Disease Drug Market Research Report 2026(Status and Outlook)
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The global Celiac Disease Drug market size was estimated at USD 791.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 14.90% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Celiac Disease Drug market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Celiac Disease Drug market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Celiac Disease Drug market.
Global Celiac Disease Drug Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
F. Hoffmann-La Roche
Johnson & Johnson
Merck
Pfizer
ADMA Biologics
Amgen
Anthera Pharmaceuticals
Bayer
Biogen
BioLineRx
Biotest
Bristol-Myers Squibb
Celgene
Takeda Pharmaceutical
Novartis
LFB Group
Kedrion Biopharma
Market Segmentation (by Type)
Distension
Diarrhea
Anorexia
Others
Market Segmentation (by Application)
First Line of Treatment
Second Line of Treatment
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Celiac Disease Drug Market
Overview of the regional outlook of the Celiac Disease Drug Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Celiac Disease Drug Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Celiac Disease Drug, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Celiac Disease Drug market size was estimated at USD 791.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 14.90% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Celiac Disease Drug market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Celiac Disease Drug market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Celiac Disease Drug market.
Global Celiac Disease Drug Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
F. Hoffmann-La Roche
Johnson & Johnson
Merck
Pfizer
ADMA Biologics
Amgen
Anthera Pharmaceuticals
Bayer
Biogen
BioLineRx
Biotest
Bristol-Myers Squibb
Celgene
Takeda Pharmaceutical
Novartis
LFB Group
Kedrion Biopharma
Market Segmentation (by Type)
Distension
Diarrhea
Anorexia
Others
Market Segmentation (by Application)
First Line of Treatment
Second Line of Treatment
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Celiac Disease Drug Market
Overview of the regional outlook of the Celiac Disease Drug Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Celiac Disease Drug Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Celiac Disease Drug, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Celiac Disease Drug
1.2 Key Market Segments
1.2.1 Celiac Disease Drug Segment by Type
1.2.2 Celiac Disease Drug Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CELIAC DISEASE DRUG MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Celiac Disease Drug Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Celiac Disease Drug Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 CELIAC DISEASE DRUG MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Celiac Disease Drug Product Life Cycle
3.3 Global Celiac Disease Drug Sales by Manufacturers (2020-2025)
3.4 Global Celiac Disease Drug Revenue Market Share by Manufacturers (2020-2025)
3.5 Celiac Disease Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Celiac Disease Drug Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Celiac Disease Drug Market Competitive Situation and Trends
3.8.1 Celiac Disease Drug Market Concentration Rate
3.8.2 Global 5 and 10 Largest Celiac Disease Drug Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 CELIAC DISEASE DRUG INDUSTRY CHAIN ANALYSIS
4.1 Celiac Disease Drug Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CELIAC DISEASE DRUG MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Celiac Disease Drug Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Celiac Disease Drug Market
5.7 ESG Ratings of Leading Companies
6 CELIAC DISEASE DRUG MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Celiac Disease Drug Sales Market Share by Type (2020-2025)
6.3 Global Celiac Disease Drug Market Size by Type (2020-2025)
6.4 Global Celiac Disease Drug Price by Type (2020-2025)
7 CELIAC DISEASE DRUG MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Celiac Disease Drug Market Sales by Application (2020-2025)
7.3 Global Celiac Disease Drug Market Size (M USD) by Application (2020-2025)
7.4 Global Celiac Disease Drug Sales Growth Rate by Application (2020-2025)
8 CELIAC DISEASE DRUG MARKET SALES BY REGION
8.1 Global Celiac Disease Drug Sales by Region
8.1.1 Global Celiac Disease Drug Sales by Region
8.1.2 Global Celiac Disease Drug Sales Market Share by Region
8.2 Global Celiac Disease Drug Market Size by Region
8.2.1 Global Celiac Disease Drug Market Size by Region
8.2.2 Global Celiac Disease Drug Market Size by Region
8.3 North America
8.3.1 North America Celiac Disease Drug Sales by Country
8.3.2 North America Celiac Disease Drug Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Celiac Disease Drug Sales by Country
8.4.2 Europe Celiac Disease Drug Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Celiac Disease Drug Sales by Region
8.5.2 Asia Pacific Celiac Disease Drug Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Celiac Disease Drug Sales by Country
8.6.2 South America Celiac Disease Drug Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Celiac Disease Drug Sales by Region
8.7.2 Middle East and Africa Celiac Disease Drug Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 CELIAC DISEASE DRUG MARKET PRODUCTION BY REGION
9.1 Global Production of Celiac Disease Drug by Region(2020-2025)
9.2 Global Celiac Disease Drug Revenue Market Share by Region (2020-2025)
9.3 Global Celiac Disease Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Celiac Disease Drug Production
9.4.1 North America Celiac Disease Drug Production Growth Rate (2020-2025)
9.4.2 North America Celiac Disease Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Celiac Disease Drug Production
9.5.1 Europe Celiac Disease Drug Production Growth Rate (2020-2025)
9.5.2 Europe Celiac Disease Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Celiac Disease Drug Production (2020-2025)
9.6.1 Japan Celiac Disease Drug Production Growth Rate (2020-2025)
9.6.2 Japan Celiac Disease Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Celiac Disease Drug Production (2020-2025)
9.7.1 China Celiac Disease Drug Production Growth Rate (2020-2025)
9.7.2 China Celiac Disease Drug Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 F. Hoffmann-La Roche
10.1.1 F. Hoffmann-La Roche Basic Information
10.1.2 F. Hoffmann-La Roche Celiac Disease Drug Product Overview
10.1.3 F. Hoffmann-La Roche Celiac Disease Drug Product Market Performance
10.1.4 F. Hoffmann-La Roche Business Overview
10.1.5 F. Hoffmann-La Roche SWOT Analysis
10.1.6 F. Hoffmann-La Roche Recent Developments
10.2 Johnson and Johnson
10.2.1 Johnson and Johnson Basic Information
10.2.2 Johnson and Johnson Celiac Disease Drug Product Overview
10.2.3 Johnson and Johnson Celiac Disease Drug Product Market Performance
10.2.4 Johnson and Johnson Business Overview
10.2.5 Johnson and Johnson SWOT Analysis
10.2.6 Johnson and Johnson Recent Developments
10.3 Merck
10.3.1 Merck Basic Information
10.3.2 Merck Celiac Disease Drug Product Overview
10.3.3 Merck Celiac Disease Drug Product Market Performance
10.3.4 Merck Business Overview
10.3.5 Merck SWOT Analysis
10.3.6 Merck Recent Developments
10.4 Pfizer
10.4.1 Pfizer Basic Information
10.4.2 Pfizer Celiac Disease Drug Product Overview
10.4.3 Pfizer Celiac Disease Drug Product Market Performance
10.4.4 Pfizer Business Overview
10.4.5 Pfizer Recent Developments
10.5 ADMA Biologics
10.5.1 ADMA Biologics Basic Information
10.5.2 ADMA Biologics Celiac Disease Drug Product Overview
10.5.3 ADMA Biologics Celiac Disease Drug Product Market Performance
10.5.4 ADMA Biologics Business Overview
10.5.5 ADMA Biologics Recent Developments
10.6 Amgen
10.6.1 Amgen Basic Information
10.6.2 Amgen Celiac Disease Drug Product Overview
10.6.3 Amgen Celiac Disease Drug Product Market Performance
10.6.4 Amgen Business Overview
10.6.5 Amgen Recent Developments
10.7 Anthera Pharmaceuticals
10.7.1 Anthera Pharmaceuticals Basic Information
10.7.2 Anthera Pharmaceuticals Celiac Disease Drug Product Overview
10.7.3 Anthera Pharmaceuticals Celiac Disease Drug Product Market Performance
10.7.4 Anthera Pharmaceuticals Business Overview
10.7.5 Anthera Pharmaceuticals Recent Developments
10.8 Bayer
10.8.1 Bayer Basic Information
10.8.2 Bayer Celiac Disease Drug Product Overview
10.8.3 Bayer Celiac Disease Drug Product Market Performance
10.8.4 Bayer Business Overview
10.8.5 Bayer Recent Developments
10.9 Biogen
10.9.1 Biogen Basic Information
10.9.2 Biogen Celiac Disease Drug Product Overview
10.9.3 Biogen Celiac Disease Drug Product Market Performance
10.9.4 Biogen Business Overview
10.9.5 Biogen Recent Developments
10.10 BioLineRx
10.10.1 BioLineRx Basic Information
10.10.2 BioLineRx Celiac Disease Drug Product Overview
10.10.3 BioLineRx Celiac Disease Drug Product Market Performance
10.10.4 BioLineRx Business Overview
10.10.5 BioLineRx Recent Developments
10.11 Biotest
10.11.1 Biotest Basic Information
10.11.2 Biotest Celiac Disease Drug Product Overview
10.11.3 Biotest Celiac Disease Drug Product Market Performance
10.11.4 Biotest Business Overview
10.11.5 Biotest Recent Developments
10.12 Bristol-Myers Squibb
10.12.1 Bristol-Myers Squibb Basic Information
10.12.2 Bristol-Myers Squibb Celiac Disease Drug Product Overview
10.12.3 Bristol-Myers Squibb Celiac Disease Drug Product Market Performance
10.12.4 Bristol-Myers Squibb Business Overview
10.12.5 Bristol-Myers Squibb Recent Developments
10.13 Celgene
10.13.1 Celgene Basic Information
10.13.2 Celgene Celiac Disease Drug Product Overview
10.13.3 Celgene Celiac Disease Drug Product Market Performance
10.13.4 Celgene Business Overview
10.13.5 Celgene Recent Developments
10.14 Takeda Pharmaceutical
10.14.1 Takeda Pharmaceutical Basic Information
10.14.2 Takeda Pharmaceutical Celiac Disease Drug Product Overview
10.14.3 Takeda Pharmaceutical Celiac Disease Drug Product Market Performance
10.14.4 Takeda Pharmaceutical Business Overview
10.14.5 Takeda Pharmaceutical Recent Developments
10.15 Novartis
10.15.1 Novartis Basic Information
10.15.2 Novartis Celiac Disease Drug Product Overview
10.15.3 Novartis Celiac Disease Drug Product Market Performance
10.15.4 Novartis Business Overview
10.15.5 Novartis Recent Developments
10.16 LFB Group
10.16.1 LFB Group Basic Information
10.16.2 LFB Group Celiac Disease Drug Product Overview
10.16.3 LFB Group Celiac Disease Drug Product Market Performance
10.16.4 LFB Group Business Overview
10.16.5 LFB Group Recent Developments
10.17 Kedrion Biopharma
10.17.1 Kedrion Biopharma Basic Information
10.17.2 Kedrion Biopharma Celiac Disease Drug Product Overview
10.17.3 Kedrion Biopharma Celiac Disease Drug Product Market Performance
10.17.4 Kedrion Biopharma Business Overview
10.17.5 Kedrion Biopharma Recent Developments
11 CELIAC DISEASE DRUG MARKET FORECAST BY REGION
11.1 Global Celiac Disease Drug Market Size Forecast
11.2 Global Celiac Disease Drug Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Celiac Disease Drug Market Size Forecast by Country
11.2.3 Asia Pacific Celiac Disease Drug Market Size Forecast by Region
11.2.4 South America Celiac Disease Drug Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Celiac Disease Drug by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Celiac Disease Drug Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Celiac Disease Drug by Type (2026-2035)
12.1.2 Global Celiac Disease Drug Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Celiac Disease Drug by Type (2026-2035)
12.2 Global Celiac Disease Drug Market Forecast by Application (2026-2035)
12.2.1 Global Celiac Disease Drug Sales (K MT) Forecast by Application
12.2.2 Global Celiac Disease Drug Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Celiac Disease Drug
1.2 Key Market Segments
1.2.1 Celiac Disease Drug Segment by Type
1.2.2 Celiac Disease Drug Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CELIAC DISEASE DRUG MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Celiac Disease Drug Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Celiac Disease Drug Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 CELIAC DISEASE DRUG MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Celiac Disease Drug Product Life Cycle
3.3 Global Celiac Disease Drug Sales by Manufacturers (2020-2025)
3.4 Global Celiac Disease Drug Revenue Market Share by Manufacturers (2020-2025)
3.5 Celiac Disease Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Celiac Disease Drug Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Celiac Disease Drug Market Competitive Situation and Trends
3.8.1 Celiac Disease Drug Market Concentration Rate
3.8.2 Global 5 and 10 Largest Celiac Disease Drug Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 CELIAC DISEASE DRUG INDUSTRY CHAIN ANALYSIS
4.1 Celiac Disease Drug Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CELIAC DISEASE DRUG MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Celiac Disease Drug Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Celiac Disease Drug Market
5.7 ESG Ratings of Leading Companies
6 CELIAC DISEASE DRUG MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Celiac Disease Drug Sales Market Share by Type (2020-2025)
6.3 Global Celiac Disease Drug Market Size by Type (2020-2025)
6.4 Global Celiac Disease Drug Price by Type (2020-2025)
7 CELIAC DISEASE DRUG MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Celiac Disease Drug Market Sales by Application (2020-2025)
7.3 Global Celiac Disease Drug Market Size (M USD) by Application (2020-2025)
7.4 Global Celiac Disease Drug Sales Growth Rate by Application (2020-2025)
8 CELIAC DISEASE DRUG MARKET SALES BY REGION
8.1 Global Celiac Disease Drug Sales by Region
8.1.1 Global Celiac Disease Drug Sales by Region
8.1.2 Global Celiac Disease Drug Sales Market Share by Region
8.2 Global Celiac Disease Drug Market Size by Region
8.2.1 Global Celiac Disease Drug Market Size by Region
8.2.2 Global Celiac Disease Drug Market Size by Region
8.3 North America
8.3.1 North America Celiac Disease Drug Sales by Country
8.3.2 North America Celiac Disease Drug Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Celiac Disease Drug Sales by Country
8.4.2 Europe Celiac Disease Drug Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Celiac Disease Drug Sales by Region
8.5.2 Asia Pacific Celiac Disease Drug Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Celiac Disease Drug Sales by Country
8.6.2 South America Celiac Disease Drug Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Celiac Disease Drug Sales by Region
8.7.2 Middle East and Africa Celiac Disease Drug Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 CELIAC DISEASE DRUG MARKET PRODUCTION BY REGION
9.1 Global Production of Celiac Disease Drug by Region(2020-2025)
9.2 Global Celiac Disease Drug Revenue Market Share by Region (2020-2025)
9.3 Global Celiac Disease Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Celiac Disease Drug Production
9.4.1 North America Celiac Disease Drug Production Growth Rate (2020-2025)
9.4.2 North America Celiac Disease Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Celiac Disease Drug Production
9.5.1 Europe Celiac Disease Drug Production Growth Rate (2020-2025)
9.5.2 Europe Celiac Disease Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Celiac Disease Drug Production (2020-2025)
9.6.1 Japan Celiac Disease Drug Production Growth Rate (2020-2025)
9.6.2 Japan Celiac Disease Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Celiac Disease Drug Production (2020-2025)
9.7.1 China Celiac Disease Drug Production Growth Rate (2020-2025)
9.7.2 China Celiac Disease Drug Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 F. Hoffmann-La Roche
10.1.1 F. Hoffmann-La Roche Basic Information
10.1.2 F. Hoffmann-La Roche Celiac Disease Drug Product Overview
10.1.3 F. Hoffmann-La Roche Celiac Disease Drug Product Market Performance
10.1.4 F. Hoffmann-La Roche Business Overview
10.1.5 F. Hoffmann-La Roche SWOT Analysis
10.1.6 F. Hoffmann-La Roche Recent Developments
10.2 Johnson and Johnson
10.2.1 Johnson and Johnson Basic Information
10.2.2 Johnson and Johnson Celiac Disease Drug Product Overview
10.2.3 Johnson and Johnson Celiac Disease Drug Product Market Performance
10.2.4 Johnson and Johnson Business Overview
10.2.5 Johnson and Johnson SWOT Analysis
10.2.6 Johnson and Johnson Recent Developments
10.3 Merck
10.3.1 Merck Basic Information
10.3.2 Merck Celiac Disease Drug Product Overview
10.3.3 Merck Celiac Disease Drug Product Market Performance
10.3.4 Merck Business Overview
10.3.5 Merck SWOT Analysis
10.3.6 Merck Recent Developments
10.4 Pfizer
10.4.1 Pfizer Basic Information
10.4.2 Pfizer Celiac Disease Drug Product Overview
10.4.3 Pfizer Celiac Disease Drug Product Market Performance
10.4.4 Pfizer Business Overview
10.4.5 Pfizer Recent Developments
10.5 ADMA Biologics
10.5.1 ADMA Biologics Basic Information
10.5.2 ADMA Biologics Celiac Disease Drug Product Overview
10.5.3 ADMA Biologics Celiac Disease Drug Product Market Performance
10.5.4 ADMA Biologics Business Overview
10.5.5 ADMA Biologics Recent Developments
10.6 Amgen
10.6.1 Amgen Basic Information
10.6.2 Amgen Celiac Disease Drug Product Overview
10.6.3 Amgen Celiac Disease Drug Product Market Performance
10.6.4 Amgen Business Overview
10.6.5 Amgen Recent Developments
10.7 Anthera Pharmaceuticals
10.7.1 Anthera Pharmaceuticals Basic Information
10.7.2 Anthera Pharmaceuticals Celiac Disease Drug Product Overview
10.7.3 Anthera Pharmaceuticals Celiac Disease Drug Product Market Performance
10.7.4 Anthera Pharmaceuticals Business Overview
10.7.5 Anthera Pharmaceuticals Recent Developments
10.8 Bayer
10.8.1 Bayer Basic Information
10.8.2 Bayer Celiac Disease Drug Product Overview
10.8.3 Bayer Celiac Disease Drug Product Market Performance
10.8.4 Bayer Business Overview
10.8.5 Bayer Recent Developments
10.9 Biogen
10.9.1 Biogen Basic Information
10.9.2 Biogen Celiac Disease Drug Product Overview
10.9.3 Biogen Celiac Disease Drug Product Market Performance
10.9.4 Biogen Business Overview
10.9.5 Biogen Recent Developments
10.10 BioLineRx
10.10.1 BioLineRx Basic Information
10.10.2 BioLineRx Celiac Disease Drug Product Overview
10.10.3 BioLineRx Celiac Disease Drug Product Market Performance
10.10.4 BioLineRx Business Overview
10.10.5 BioLineRx Recent Developments
10.11 Biotest
10.11.1 Biotest Basic Information
10.11.2 Biotest Celiac Disease Drug Product Overview
10.11.3 Biotest Celiac Disease Drug Product Market Performance
10.11.4 Biotest Business Overview
10.11.5 Biotest Recent Developments
10.12 Bristol-Myers Squibb
10.12.1 Bristol-Myers Squibb Basic Information
10.12.2 Bristol-Myers Squibb Celiac Disease Drug Product Overview
10.12.3 Bristol-Myers Squibb Celiac Disease Drug Product Market Performance
10.12.4 Bristol-Myers Squibb Business Overview
10.12.5 Bristol-Myers Squibb Recent Developments
10.13 Celgene
10.13.1 Celgene Basic Information
10.13.2 Celgene Celiac Disease Drug Product Overview
10.13.3 Celgene Celiac Disease Drug Product Market Performance
10.13.4 Celgene Business Overview
10.13.5 Celgene Recent Developments
10.14 Takeda Pharmaceutical
10.14.1 Takeda Pharmaceutical Basic Information
10.14.2 Takeda Pharmaceutical Celiac Disease Drug Product Overview
10.14.3 Takeda Pharmaceutical Celiac Disease Drug Product Market Performance
10.14.4 Takeda Pharmaceutical Business Overview
10.14.5 Takeda Pharmaceutical Recent Developments
10.15 Novartis
10.15.1 Novartis Basic Information
10.15.2 Novartis Celiac Disease Drug Product Overview
10.15.3 Novartis Celiac Disease Drug Product Market Performance
10.15.4 Novartis Business Overview
10.15.5 Novartis Recent Developments
10.16 LFB Group
10.16.1 LFB Group Basic Information
10.16.2 LFB Group Celiac Disease Drug Product Overview
10.16.3 LFB Group Celiac Disease Drug Product Market Performance
10.16.4 LFB Group Business Overview
10.16.5 LFB Group Recent Developments
10.17 Kedrion Biopharma
10.17.1 Kedrion Biopharma Basic Information
10.17.2 Kedrion Biopharma Celiac Disease Drug Product Overview
10.17.3 Kedrion Biopharma Celiac Disease Drug Product Market Performance
10.17.4 Kedrion Biopharma Business Overview
10.17.5 Kedrion Biopharma Recent Developments
11 CELIAC DISEASE DRUG MARKET FORECAST BY REGION
11.1 Global Celiac Disease Drug Market Size Forecast
11.2 Global Celiac Disease Drug Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Celiac Disease Drug Market Size Forecast by Country
11.2.3 Asia Pacific Celiac Disease Drug Market Size Forecast by Region
11.2.4 South America Celiac Disease Drug Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Celiac Disease Drug by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Celiac Disease Drug Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Celiac Disease Drug by Type (2026-2035)
12.1.2 Global Celiac Disease Drug Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Celiac Disease Drug by Type (2026-2035)
12.2 Global Celiac Disease Drug Market Forecast by Application (2026-2035)
12.2.1 Global Celiac Disease Drug Sales (K MT) Forecast by Application
12.2.2 Global Celiac Disease Drug Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Celiac Disease Drug Market Size by Type (M USD)
Table 4. Global Celiac Disease Drug Market Size by Application
Table 5. Celiac Disease Drug Market Size Comparison by Region (M USD)
Table 6. Global Celiac Disease Drug Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Celiac Disease Drug Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Celiac Disease Drug Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Celiac Disease Drug Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Celiac Disease Drug as of 2025)
Table 11. Global Market Celiac Disease Drug Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Celiac Disease Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Celiac Disease Drug Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Celiac Disease Drug Sales by Type (K MT)
Table 27. Global Celiac Disease Drug Market Size by Type (M USD)
Table 28. Global Celiac Disease Drug Sales (K MT) by Type (2020-2025)
Table 29. Global Celiac Disease Drug Sales Market Share by Type (2020-2025)
Table 30. Global Celiac Disease Drug Market Size (M USD) by Type (2020-2025)
Table 31. Global Celiac Disease Drug Market Share by Type (2020-2025)
Table 32. Global Celiac Disease Drug Price (USD/KG) by Type (2020-2025)
Table 33. Global Celiac Disease Drug Sales (K MT) by Application
Table 34. Global Celiac Disease Drug Market Size by Application
Table 35. Global Celiac Disease Drug Sales by Application (2020-2025) & (K MT)
Table 36. Global Celiac Disease Drug Sales Market Share by Application (2020-2025)
Table 37. Global Celiac Disease Drug Market Size by Application (2020-2025) & (M USD)
Table 38. Global Celiac Disease Drug Market Share by Application (2020-2025)
Table 39. Global Celiac Disease Drug Sales Growth Rate by Application (2020-2025)
Table 40. Global Celiac Disease Drug Sales by Region (2020-2025) & (K MT)
Table 41. Global Celiac Disease Drug Sales Market Share by Region (2020-2025)
Table 42. Global Celiac Disease Drug Market Size by Region (2020-2025) & (M USD)
Table 43. Global Celiac Disease Drug Market Size by Region (2020-2025)
Table 44. North America Celiac Disease Drug Sales by Country (2020-2025) & (K MT)
Table 45. North America Celiac Disease Drug Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Celiac Disease Drug Sales by Country (2020-2025) & (K MT)
Table 47. Europe Celiac Disease Drug Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Celiac Disease Drug Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Celiac Disease Drug Market Size by Region (2020-2025) & (M USD)
Table 50. South America Celiac Disease Drug Sales by Country (2020-2025) & (K MT)
Table 51. South America Celiac Disease Drug Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Celiac Disease Drug Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Celiac Disease Drug Market Size by Region (2020-2025) & (M USD)
Table 54. Global Celiac Disease Drug Production (K MT) by Region(2020-2025)
Table 55. Global Celiac Disease Drug Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Celiac Disease Drug Revenue Market Share by Region (2020-2025)
Table 57. Global Celiac Disease Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Celiac Disease Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Celiac Disease Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Celiac Disease Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Celiac Disease Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. F. Hoffmann-La Roche Basic Information
Table 63. F. Hoffmann-La Roche Celiac Disease Drug Product Overview
Table 64. F. Hoffmann-La Roche Celiac Disease Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. F. Hoffmann-La Roche Business Overview
Table 66. F. Hoffmann-La Roche SWOT Analysis
Table 67. F. Hoffmann-La Roche Recent Developments
Table 68. Johnson and Johnson Basic Information
Table 69. Johnson and Johnson Celiac Disease Drug Product Overview
Table 70. Johnson and Johnson Celiac Disease Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Johnson and Johnson Business Overview
Table 72. Johnson and Johnson SWOT Analysis
Table 73. Johnson and Johnson Recent Developments
Table 74. Merck Basic Information
Table 75. Merck Celiac Disease Drug Product Overview
Table 76. Merck Celiac Disease Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Merck Business Overview
Table 78. Merck SWOT Analysis
Table 79. Merck Recent Developments
Table 80. Pfizer Basic Information
Table 81. Pfizer Celiac Disease Drug Product Overview
Table 82. Pfizer Celiac Disease Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Pfizer Business Overview
Table 84. Pfizer Recent Developments
Table 85. ADMA Biologics Basic Information
Table 86. ADMA Biologics Celiac Disease Drug Product Overview
Table 87. ADMA Biologics Celiac Disease Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. ADMA Biologics Business Overview
Table 89. ADMA Biologics Recent Developments
Table 90. Amgen Basic Information
Table 91. Amgen Celiac Disease Drug Product Overview
Table 92. Amgen Celiac Disease Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Amgen Business Overview
Table 94. Amgen Recent Developments
Table 95. Anthera Pharmaceuticals Basic Information
Table 96. Anthera Pharmaceuticals Celiac Disease Drug Product Overview
Table 97. Anthera Pharmaceuticals Celiac Disease Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Anthera Pharmaceuticals Business Overview
Table 99. Anthera Pharmaceuticals Recent Developments
Table 100. Bayer Basic Information
Table 101. Bayer Celiac Disease Drug Product Overview
Table 102. Bayer Celiac Disease Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Bayer Business Overview
Table 104. Bayer Recent Developments
Table 105. Biogen Basic Information
Table 106. Biogen Celiac Disease Drug Product Overview
Table 107. Biogen Celiac Disease Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Biogen Business Overview
Table 109. Biogen Recent Developments
Table 110. BioLineRx Basic Information
Table 111. BioLineRx Celiac Disease Drug Product Overview
Table 112. BioLineRx Celiac Disease Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. BioLineRx Business Overview
Table 114. BioLineRx Recent Developments
Table 115. Biotest Basic Information
Table 116. Biotest Celiac Disease Drug Product Overview
Table 117. Biotest Celiac Disease Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Biotest Business Overview
Table 119. Biotest Recent Developments
Table 120. Bristol-Myers Squibb Basic Information
Table 121. Bristol-Myers Squibb Celiac Disease Drug Product Overview
Table 122. Bristol-Myers Squibb Celiac Disease Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. Bristol-Myers Squibb Business Overview
Table 124. Bristol-Myers Squibb Recent Developments
Table 125. Celgene Basic Information
Table 126. Celgene Celiac Disease Drug Product Overview
Table 127. Celgene Celiac Disease Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. Celgene Business Overview
Table 129. Celgene Recent Developments
Table 130. Takeda Pharmaceutical Basic Information
Table 131. Takeda Pharmaceutical Celiac Disease Drug Product Overview
Table 132. Takeda Pharmaceutical Celiac Disease Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 133. Takeda Pharmaceutical Business Overview
Table 134. Takeda Pharmaceutical Recent Developments
Table 135. Novartis Basic Information
Table 136. Novartis Celiac Disease Drug Product Overview
Table 137. Novartis Celiac Disease Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 138. Novartis Business Overview
Table 139. Novartis Recent Developments
Table 140. LFB Group Basic Information
Table 141. LFB Group Celiac Disease Drug Product Overview
Table 142. LFB Group Celiac Disease Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 143. LFB Group Business Overview
Table 144. LFB Group Recent Developments
Table 145. Kedrion Biopharma Basic Information
Table 146. Kedrion Biopharma Celiac Disease Drug Product Overview
Table 147. Kedrion Biopharma Celiac Disease Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 148. Kedrion Biopharma Business Overview
Table 149. Kedrion Biopharma Recent Developments
Table 150. Global Celiac Disease Drug Sales Forecast by Region (2026-2035) & (K MT)
Table 151. Global Celiac Disease Drug Market Size Forecast by Region (2026-2035) & (M USD)
Table 152. North America Celiac Disease Drug Sales Forecast by Country (2026-2035) & (K MT)
Table 153. North America Celiac Disease Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 154. Europe Celiac Disease Drug Sales Forecast by Country (2026-2035) & (K MT)
Table 155. Europe Celiac Disease Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 156. Asia Pacific Celiac Disease Drug Sales Forecast by Region (2026-2035) & (K MT)
Table 157. Asia Pacific Celiac Disease Drug Market Size Forecast by Region (2026-2035) & (M USD)
Table 158. South America Celiac Disease Drug Sales Forecast by Country (2026-2035) & (K MT)
Table 159. South America Celiac Disease Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 160. Middle East and Africa Celiac Disease Drug Sales Forecast by Country (2026-2035) & (Units)
Table 161. Middle East and Africa Celiac Disease Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 162. Global Celiac Disease Drug Sales Forecast by Type (2026-2035) & (K MT)
Table 163. Global Celiac Disease Drug Market Size Forecast by Type (2026-2035) & (M USD)
Table 164. Global Celiac Disease Drug Price Forecast by Type (2026-2035) & (USD/KG)
Table 165. Global Celiac Disease Drug Sales (K MT) Forecast by Application (2026-2035)
Table 166. Global Celiac Disease Drug Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Celiac Disease Drug Market Size by Type (M USD)
Table 4. Global Celiac Disease Drug Market Size by Application
Table 5. Celiac Disease Drug Market Size Comparison by Region (M USD)
Table 6. Global Celiac Disease Drug Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Celiac Disease Drug Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Celiac Disease Drug Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Celiac Disease Drug Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Celiac Disease Drug as of 2025)
Table 11. Global Market Celiac Disease Drug Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Celiac Disease Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Celiac Disease Drug Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Celiac Disease Drug Sales by Type (K MT)
Table 27. Global Celiac Disease Drug Market Size by Type (M USD)
Table 28. Global Celiac Disease Drug Sales (K MT) by Type (2020-2025)
Table 29. Global Celiac Disease Drug Sales Market Share by Type (2020-2025)
Table 30. Global Celiac Disease Drug Market Size (M USD) by Type (2020-2025)
Table 31. Global Celiac Disease Drug Market Share by Type (2020-2025)
Table 32. Global Celiac Disease Drug Price (USD/KG) by Type (2020-2025)
Table 33. Global Celiac Disease Drug Sales (K MT) by Application
Table 34. Global Celiac Disease Drug Market Size by Application
Table 35. Global Celiac Disease Drug Sales by Application (2020-2025) & (K MT)
Table 36. Global Celiac Disease Drug Sales Market Share by Application (2020-2025)
Table 37. Global Celiac Disease Drug Market Size by Application (2020-2025) & (M USD)
Table 38. Global Celiac Disease Drug Market Share by Application (2020-2025)
Table 39. Global Celiac Disease Drug Sales Growth Rate by Application (2020-2025)
Table 40. Global Celiac Disease Drug Sales by Region (2020-2025) & (K MT)
Table 41. Global Celiac Disease Drug Sales Market Share by Region (2020-2025)
Table 42. Global Celiac Disease Drug Market Size by Region (2020-2025) & (M USD)
Table 43. Global Celiac Disease Drug Market Size by Region (2020-2025)
Table 44. North America Celiac Disease Drug Sales by Country (2020-2025) & (K MT)
Table 45. North America Celiac Disease Drug Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Celiac Disease Drug Sales by Country (2020-2025) & (K MT)
Table 47. Europe Celiac Disease Drug Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Celiac Disease Drug Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Celiac Disease Drug Market Size by Region (2020-2025) & (M USD)
Table 50. South America Celiac Disease Drug Sales by Country (2020-2025) & (K MT)
Table 51. South America Celiac Disease Drug Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Celiac Disease Drug Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Celiac Disease Drug Market Size by Region (2020-2025) & (M USD)
Table 54. Global Celiac Disease Drug Production (K MT) by Region(2020-2025)
Table 55. Global Celiac Disease Drug Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Celiac Disease Drug Revenue Market Share by Region (2020-2025)
Table 57. Global Celiac Disease Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Celiac Disease Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Celiac Disease Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Celiac Disease Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Celiac Disease Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. F. Hoffmann-La Roche Basic Information
Table 63. F. Hoffmann-La Roche Celiac Disease Drug Product Overview
Table 64. F. Hoffmann-La Roche Celiac Disease Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. F. Hoffmann-La Roche Business Overview
Table 66. F. Hoffmann-La Roche SWOT Analysis
Table 67. F. Hoffmann-La Roche Recent Developments
Table 68. Johnson and Johnson Basic Information
Table 69. Johnson and Johnson Celiac Disease Drug Product Overview
Table 70. Johnson and Johnson Celiac Disease Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Johnson and Johnson Business Overview
Table 72. Johnson and Johnson SWOT Analysis
Table 73. Johnson and Johnson Recent Developments
Table 74. Merck Basic Information
Table 75. Merck Celiac Disease Drug Product Overview
Table 76. Merck Celiac Disease Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Merck Business Overview
Table 78. Merck SWOT Analysis
Table 79. Merck Recent Developments
Table 80. Pfizer Basic Information
Table 81. Pfizer Celiac Disease Drug Product Overview
Table 82. Pfizer Celiac Disease Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Pfizer Business Overview
Table 84. Pfizer Recent Developments
Table 85. ADMA Biologics Basic Information
Table 86. ADMA Biologics Celiac Disease Drug Product Overview
Table 87. ADMA Biologics Celiac Disease Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. ADMA Biologics Business Overview
Table 89. ADMA Biologics Recent Developments
Table 90. Amgen Basic Information
Table 91. Amgen Celiac Disease Drug Product Overview
Table 92. Amgen Celiac Disease Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Amgen Business Overview
Table 94. Amgen Recent Developments
Table 95. Anthera Pharmaceuticals Basic Information
Table 96. Anthera Pharmaceuticals Celiac Disease Drug Product Overview
Table 97. Anthera Pharmaceuticals Celiac Disease Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Anthera Pharmaceuticals Business Overview
Table 99. Anthera Pharmaceuticals Recent Developments
Table 100. Bayer Basic Information
Table 101. Bayer Celiac Disease Drug Product Overview
Table 102. Bayer Celiac Disease Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Bayer Business Overview
Table 104. Bayer Recent Developments
Table 105. Biogen Basic Information
Table 106. Biogen Celiac Disease Drug Product Overview
Table 107. Biogen Celiac Disease Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Biogen Business Overview
Table 109. Biogen Recent Developments
Table 110. BioLineRx Basic Information
Table 111. BioLineRx Celiac Disease Drug Product Overview
Table 112. BioLineRx Celiac Disease Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. BioLineRx Business Overview
Table 114. BioLineRx Recent Developments
Table 115. Biotest Basic Information
Table 116. Biotest Celiac Disease Drug Product Overview
Table 117. Biotest Celiac Disease Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Biotest Business Overview
Table 119. Biotest Recent Developments
Table 120. Bristol-Myers Squibb Basic Information
Table 121. Bristol-Myers Squibb Celiac Disease Drug Product Overview
Table 122. Bristol-Myers Squibb Celiac Disease Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. Bristol-Myers Squibb Business Overview
Table 124. Bristol-Myers Squibb Recent Developments
Table 125. Celgene Basic Information
Table 126. Celgene Celiac Disease Drug Product Overview
Table 127. Celgene Celiac Disease Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. Celgene Business Overview
Table 129. Celgene Recent Developments
Table 130. Takeda Pharmaceutical Basic Information
Table 131. Takeda Pharmaceutical Celiac Disease Drug Product Overview
Table 132. Takeda Pharmaceutical Celiac Disease Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 133. Takeda Pharmaceutical Business Overview
Table 134. Takeda Pharmaceutical Recent Developments
Table 135. Novartis Basic Information
Table 136. Novartis Celiac Disease Drug Product Overview
Table 137. Novartis Celiac Disease Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 138. Novartis Business Overview
Table 139. Novartis Recent Developments
Table 140. LFB Group Basic Information
Table 141. LFB Group Celiac Disease Drug Product Overview
Table 142. LFB Group Celiac Disease Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 143. LFB Group Business Overview
Table 144. LFB Group Recent Developments
Table 145. Kedrion Biopharma Basic Information
Table 146. Kedrion Biopharma Celiac Disease Drug Product Overview
Table 147. Kedrion Biopharma Celiac Disease Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 148. Kedrion Biopharma Business Overview
Table 149. Kedrion Biopharma Recent Developments
Table 150. Global Celiac Disease Drug Sales Forecast by Region (2026-2035) & (K MT)
Table 151. Global Celiac Disease Drug Market Size Forecast by Region (2026-2035) & (M USD)
Table 152. North America Celiac Disease Drug Sales Forecast by Country (2026-2035) & (K MT)
Table 153. North America Celiac Disease Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 154. Europe Celiac Disease Drug Sales Forecast by Country (2026-2035) & (K MT)
Table 155. Europe Celiac Disease Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 156. Asia Pacific Celiac Disease Drug Sales Forecast by Region (2026-2035) & (K MT)
Table 157. Asia Pacific Celiac Disease Drug Market Size Forecast by Region (2026-2035) & (M USD)
Table 158. South America Celiac Disease Drug Sales Forecast by Country (2026-2035) & (K MT)
Table 159. South America Celiac Disease Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 160. Middle East and Africa Celiac Disease Drug Sales Forecast by Country (2026-2035) & (Units)
Table 161. Middle East and Africa Celiac Disease Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 162. Global Celiac Disease Drug Sales Forecast by Type (2026-2035) & (K MT)
Table 163. Global Celiac Disease Drug Market Size Forecast by Type (2026-2035) & (M USD)
Table 164. Global Celiac Disease Drug Price Forecast by Type (2026-2035) & (USD/KG)
Table 165. Global Celiac Disease Drug Sales (K MT) Forecast by Application (2026-2035)
Table 166. Global Celiac Disease Drug Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Celiac Disease Drug
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Celiac Disease Drug Market Size (M USD), 2025-2035
Figure 5. Global Celiac Disease Drug Market Size (M USD) (2020-2035)
Figure 6. Global Celiac Disease Drug Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Celiac Disease Drug Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Celiac Disease Drug Product Life Cycle
Figure 13. Celiac Disease Drug Sales Share by Manufacturers in 2025
Figure 14. Global Celiac Disease Drug Revenue Share by Manufacturers in 2025
Figure 15. Celiac Disease Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Celiac Disease Drug Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Celiac Disease Drug Revenue in 2025
Figure 18. Industry Chain Map of Celiac Disease Drug
Figure 19. Global Celiac Disease Drug Market PEST Analysis
Figure 20. Global Celiac Disease Drug Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Celiac Disease Drug Market Share by Type
Figure 27. Sales Market Share of Celiac Disease Drug by Type (2020-2025)
Figure 28. Sales Market Share of Celiac Disease Drug by Type in 2025
Figure 29. Market Share of Celiac Disease Drug by Type (2020-2025)
Figure 30. Market Share of Celiac Disease Drug by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Celiac Disease Drug Market Share by Application
Figure 33. Global Celiac Disease Drug Sales Market Share by Application (2020-2025)
Figure 34. Global Celiac Disease Drug Sales Market Share by Application in 2025
Figure 35. Global Celiac Disease Drug Market Share by Application (2020-2025)
Figure 36. Global Celiac Disease Drug Market Share by Application in 2025
Figure 37. Global Celiac Disease Drug Sales Growth Rate by Application (2020-2025)
Figure 38. Global Celiac Disease Drug Sales Market Share by Region (2020-2025)
Figure 39. Global Celiac Disease Drug Market Size by Region (2020-2025)
Figure 40. North America Celiac Disease Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Celiac Disease Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Celiac Disease Drug Sales Market Share by Country in 2024
Figure 43. North America Celiac Disease Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Celiac Disease Drug Market Size by Country in 2024
Figure 45. U.S. Celiac Disease Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Celiac Disease Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Celiac Disease Drug Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Celiac Disease Drug Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Celiac Disease Drug Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Celiac Disease Drug Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Celiac Disease Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Celiac Disease Drug Sales Market Share by Country in 2024
Figure 53. Europe Celiac Disease Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Celiac Disease Drug Market Size by Country in 2024
Figure 55. Germany Celiac Disease Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Celiac Disease Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Celiac Disease Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Celiac Disease Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Celiac Disease Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Celiac Disease Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Celiac Disease Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Celiac Disease Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Celiac Disease Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Celiac Disease Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Celiac Disease Drug Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Celiac Disease Drug Sales Market Share by Region in 2024
Figure 67. Asia Pacific Celiac Disease Drug Market Size by Region in 2024
Figure 68. China Celiac Disease Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Celiac Disease Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Celiac Disease Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Celiac Disease Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Celiac Disease Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Celiac Disease Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Celiac Disease Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Celiac Disease Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Celiac Disease Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Celiac Disease Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Celiac Disease Drug Sales and Growth Rate (K MT)
Figure 79. South America Celiac Disease Drug Sales Market Share by Country in 2024
Figure 80. South America Celiac Disease Drug Market Size and Growth Rate (M USD)
Figure 81. South America Celiac Disease Drug Market Size by Country in 2024
Figure 82. Brazil Celiac Disease Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Celiac Disease Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Celiac Disease Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Celiac Disease Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Celiac Disease Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Celiac Disease Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Celiac Disease Drug Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Celiac Disease Drug Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Celiac Disease Drug Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Celiac Disease Drug Market Size by Region in 2024
Figure 92. Saudi Arabia Celiac Disease Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Celiac Disease Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Celiac Disease Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Celiac Disease Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Celiac Disease Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Celiac Disease Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Celiac Disease Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Celiac Disease Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Celiac Disease Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Celiac Disease Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Celiac Disease Drug Production Market Share by Region (2020-2025)
Figure 103. North America Celiac Disease Drug Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Celiac Disease Drug Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Celiac Disease Drug Production (K MT) Growth Rate (2020-2025)
Figure 106. China Celiac Disease Drug Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Celiac Disease Drug Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Celiac Disease Drug Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Celiac Disease Drug Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Celiac Disease Drug Market Share Forecast by Type (2026-2035)
Figure 111. Global Celiac Disease Drug Sales Forecast by Application (2026-2035)
Figure 112. Global Celiac Disease Drug Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Celiac Disease Drug
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Celiac Disease Drug Market Size (M USD), 2025-2035
Figure 5. Global Celiac Disease Drug Market Size (M USD) (2020-2035)
Figure 6. Global Celiac Disease Drug Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Celiac Disease Drug Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Celiac Disease Drug Product Life Cycle
Figure 13. Celiac Disease Drug Sales Share by Manufacturers in 2025
Figure 14. Global Celiac Disease Drug Revenue Share by Manufacturers in 2025
Figure 15. Celiac Disease Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Celiac Disease Drug Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Celiac Disease Drug Revenue in 2025
Figure 18. Industry Chain Map of Celiac Disease Drug
Figure 19. Global Celiac Disease Drug Market PEST Analysis
Figure 20. Global Celiac Disease Drug Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Celiac Disease Drug Market Share by Type
Figure 27. Sales Market Share of Celiac Disease Drug by Type (2020-2025)
Figure 28. Sales Market Share of Celiac Disease Drug by Type in 2025
Figure 29. Market Share of Celiac Disease Drug by Type (2020-2025)
Figure 30. Market Share of Celiac Disease Drug by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Celiac Disease Drug Market Share by Application
Figure 33. Global Celiac Disease Drug Sales Market Share by Application (2020-2025)
Figure 34. Global Celiac Disease Drug Sales Market Share by Application in 2025
Figure 35. Global Celiac Disease Drug Market Share by Application (2020-2025)
Figure 36. Global Celiac Disease Drug Market Share by Application in 2025
Figure 37. Global Celiac Disease Drug Sales Growth Rate by Application (2020-2025)
Figure 38. Global Celiac Disease Drug Sales Market Share by Region (2020-2025)
Figure 39. Global Celiac Disease Drug Market Size by Region (2020-2025)
Figure 40. North America Celiac Disease Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Celiac Disease Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Celiac Disease Drug Sales Market Share by Country in 2024
Figure 43. North America Celiac Disease Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Celiac Disease Drug Market Size by Country in 2024
Figure 45. U.S. Celiac Disease Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Celiac Disease Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Celiac Disease Drug Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Celiac Disease Drug Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Celiac Disease Drug Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Celiac Disease Drug Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Celiac Disease Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Celiac Disease Drug Sales Market Share by Country in 2024
Figure 53. Europe Celiac Disease Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Celiac Disease Drug Market Size by Country in 2024
Figure 55. Germany Celiac Disease Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Celiac Disease Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Celiac Disease Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Celiac Disease Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Celiac Disease Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Celiac Disease Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Celiac Disease Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Celiac Disease Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Celiac Disease Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Celiac Disease Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Celiac Disease Drug Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Celiac Disease Drug Sales Market Share by Region in 2024
Figure 67. Asia Pacific Celiac Disease Drug Market Size by Region in 2024
Figure 68. China Celiac Disease Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Celiac Disease Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Celiac Disease Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Celiac Disease Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Celiac Disease Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Celiac Disease Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Celiac Disease Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Celiac Disease Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Celiac Disease Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Celiac Disease Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Celiac Disease Drug Sales and Growth Rate (K MT)
Figure 79. South America Celiac Disease Drug Sales Market Share by Country in 2024
Figure 80. South America Celiac Disease Drug Market Size and Growth Rate (M USD)
Figure 81. South America Celiac Disease Drug Market Size by Country in 2024
Figure 82. Brazil Celiac Disease Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Celiac Disease Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Celiac Disease Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Celiac Disease Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Celiac Disease Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Celiac Disease Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Celiac Disease Drug Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Celiac Disease Drug Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Celiac Disease Drug Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Celiac Disease Drug Market Size by Region in 2024
Figure 92. Saudi Arabia Celiac Disease Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Celiac Disease Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Celiac Disease Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Celiac Disease Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Celiac Disease Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Celiac Disease Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Celiac Disease Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Celiac Disease Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Celiac Disease Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Celiac Disease Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Celiac Disease Drug Production Market Share by Region (2020-2025)
Figure 103. North America Celiac Disease Drug Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Celiac Disease Drug Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Celiac Disease Drug Production (K MT) Growth Rate (2020-2025)
Figure 106. China Celiac Disease Drug Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Celiac Disease Drug Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Celiac Disease Drug Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Celiac Disease Drug Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Celiac Disease Drug Market Share Forecast by Type (2026-2035)
Figure 111. Global Celiac Disease Drug Sales Forecast by Application (2026-2035)
Figure 112. Global Celiac Disease Drug Market Share Forecast by Application (2026-2035)
